Fc gamma RIIa polymorphism in human immunodeficiency virus-infected children with invasive pneumococcal disease

被引:7
作者
Abadi, J
Zhong, ZJ
Dobroszycki, J
Pirofski, LA
机构
[1] YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT MED,BRONX,NY 10461
[2] YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT PEDIAT,DIV INFECT DIS,BRONX,NY 10461
[3] YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT IMMUNOL MICROBIOL,BRONX,NY 10461
[4] BRONX LEBANON HOSP CTR,DEPT PEDIAT,DIV INFECT DIS,BRONX,NY 10456
关键词
D O I
10.1203/00006450-199709000-00002
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Invasive pneumococcal disease (IPD) occurs frequently in HIV-infected children and adults. Defects in complement func tion, opsonic capsular antibodies, and Fc receptor antibody mediated phagocytosis could contribute to impaired host defense against Streptococcus pneumoniae. The objective of this study was to define the distribution of the three Fc gamma RIIa genotypes in HIV+ children, including those with IPD. Forty-eight HIV+ Hispanic children, including eight with IPD, followed at Bronx-Lebanon Hospital Center, Bronx, New York, nine HIV+ adults with IPD, and 56 HIV- Hispanic control subjects were studied. The children and adults were identified retrospectively except for one child who developed TPD during the study. Fc gamma RIIa genotypes were determined by PCR amplification of the Fc gamma RIIa locus from genomic DNA samples and hybridization of the PCR products with allele-specific oligonucleotides. Naturally occurring serum antibodies reactive with four pneumococcal polysaccharide serotypes were determined by ELISA in seven of eight children with IPD. There were no statistical differences in Fc gamma RIIa genotypes between HIV+ children with and without IPD, HIV+ adults with IPD, or HN-Hispanics. The predominant IgG subclass of pneumococcal polysaccharide binding antibodies in the seven HIV+ children with IPD studied was IgG,. The distribution of Fc gamma RIIa genotypes in HIV+ children with and without IPD is similar to that of the normal Hispanic population. The prospect of passive immunotherapy with specific anticapsular antibodies might be a promising alternative for the treatment and/or prevention of IPD in HIV+ children and other immunodeficient groups.
引用
收藏
页码:259 / 262
页数:4
相关论文
共 29 条
[1]   STREPTOCOCCUS-PNEUMONIAE - VIRULENCE FACTORS, PATHOGENESIS, AND VACCINES [J].
ALONSODEVELASCO, E ;
VERHEUL, AFM ;
VERHOEF, J ;
SNIPPE, H .
MICROBIOLOGICAL REVIEWS, 1995, 59 (04) :591-&
[2]   ANTIBODIES TO PNEUMOCOCCAL CAPSULAR POLYSACCHARIDES IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION GIVEN POLYVALENT PNEUMOCOCCAL VACCINE [J].
ARPADI, SM ;
BACK, S ;
OBRIEN, J ;
JANOFF, EN .
JOURNAL OF PEDIATRICS, 1994, 125 (01) :77-79
[3]   FC-GAMMA RECEPTOR IIA (CD32) POLYMORPHISM IN FULMINANT MENINGOCOCCAL SEPTIC SHOCK IN CHILDREN [J].
BREDIUS, RGM ;
DERKX, BHF ;
FIJEN, CAP ;
DEWIT, TPM ;
DEHAAS, M ;
WEENING, RS ;
VANDEWINKEL, JGJ ;
OUT, TA .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (04) :848-853
[4]   FC-RECEPTORS EXPRESSION AND FUNCTION IN MONONUCLEAR PHAGOCYTES FROM AIDS PATIENTS - MODULATION BY IFN-GAMMA [J].
CAPSONI, F ;
MINONZIO, F ;
ONGARI, AM ;
BONARA, P ;
PINTO, G ;
CARBONELLI, V ;
LAZZARIN, A ;
ZANUSSI, C .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1994, 39 (01) :45-50
[5]   INVASIVE PNEUMOCOCCAL DISEASE AMONG INFECTED AND UNINFECTED CHILDREN OF MOTHERS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
FARLEY, JJ ;
KING, JC ;
NAIR, P ;
HINES, SE ;
TRESSLER, RL ;
VINK, PE .
JOURNAL OF PEDIATRICS, 1994, 124 (06) :853-858
[6]  
FERRANTE A, 1990, PEDIATR INFECT DIS J, V9, pS16
[7]   POLYMORPHISM OF IGG FC-RECEPTORS IN MENINGOCOCCAL DISEASE [J].
FIJEN, CAP ;
BREDIUS, RGM ;
KUIJPER, EJ .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (07) :636-636
[8]  
FISCHER GW, 1992, INFECT DIS CLIN N AM, V6, P97
[9]  
FRENCH MAH, 1990, PEDIATR INFECT DIS J, V9, pS46
[10]   PNEUMOCOCCAL IMMUNITY AND RESPONSE TO IMMUNIZATION WITH PNEUMOCOCCAL VACCINE IN BONE-MARROW TRANSPLANT PATIENTS - THE INFLUENCE OF GRAFT-VERSUS-HOST REACTION [J].
HAMMARSTROM, V ;
PAUKSEN, K ;
AZINGE, J ;
OBERG, G ;
LJUNGMAN, P .
SUPPORTIVE CARE IN CANCER, 1993, 1 (04) :195-199